What is the main function of the targeted drug cabozantinib?

Cabozantinib, as a new targeted drug, has received widespread attention in cancer treatment in recent years. Cabozantinib is a tyrosinase receptor antagonist. It can inhibit the growth and spread of tumor cells by inhibiting tyrosinase activity. Specifically, cabozantinib can kill tumor cells, reduce metastasis, and inhibit tumor angiogenesis, thereby effectively controlling cancer progression.

Cabotinib was first approved by the U.S. Food and Drug Administration for the treatment of metastatic medullary thyroid cancer in2012. This shows the significant efficacy of cabozantinib in targeting this specific cancer type.

In 2016, cabozantinib was further approved by the USFDA for the treatment of advanced renal cancer that has failed first-line anti-angiogenic drugs. This approval expands the clinical scope of cabozantinib and provides a new treatment option for patients with advanced kidney cancer.

In addition to the two cancers mentioned above, cabozantinib has also shown therapeutic potential in a variety of other tumors. Including lung cancer, liver cancer, non-small cell lung cancer, etc., cabozantinib can exert a certain effect. Especially in non-small cell lung cancer, the performance of cabozantinib has attracted much attention, bringing new hope to these patients.

Although cabozantinib has excellent anti-tumor effects, it may also cause some adverse effects. Common adverse reactions include diarrhea, stomatitis, etc. In addition, patients may also experience symptoms such as loss of appetite, fatigue, nausea, vomiting, and high blood pressure. Therefore, when using cabozantinib, it is necessary to pay close attention to the patient's response and adjust the treatment plan in a timely manner according to the situation.

Cabozantinib, as a pleiotropic targeted drug, plays an important role in cancer treatment. It fights tumors by inhibiting tyrosinase activity, providing new treatment strategies for patients with various cancers. However, it is also necessary to be alert to possible adverse reactions during use to ensure the safety and health of patients.